Thursday, 21 May 2020 | 3:00 pm JST
Businesses in Japan and around the globe are experiencing significant challenges as a result of COVID-19. In this 60-minute webinar, Tokyo partner Hiroto Imai, Tokyo counsel Seiji Niwa,...
23 April 2020 | 15:00 pm - 16:00 pm JST
Businesses in Japan and around the globe are experiencing significant challenges as a result of COVID-19. In this 60-minute webinar, Tokyo partner Hiroto Imai, Tokyo counsel Seiji Niwa,...
30 October 2019 | 1:30 PM - 6:00 PM (TST)
Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.
30 October 2019 | 1:30 PM - 6:00 PM (TST)
Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.
12 September 2019
12 September 2019
25 April 2019
Japan is the latest country to pass a new law, “the Act regarding the Promotion of Use of Sea Areas to Develop Offshore Renewable Energy Facilities" (Saiene Kaiiki Riyou Hou), to ...
14 March 2019
In 2018 business headlines were dominated by Japanese M&A deals at levels unprecedented since the 1980s. This trend is expected to continue in tech M&A with Japanese investors...
